P. Cacoub, T. Poynard, P. Ghillani, C. F. Olivi, M. Piette et al., Extrahepatic manifestations of chronic hepatitis C, Arthritis & Rheumatism, vol.59, issue.10, pp.2204-2216, 1999.
DOI : 10.1159/000007517
URL : https://hal.archives-ouvertes.fr/hal-01159323

P. Cacoub, C. Comarmond, F. Domont, L. Savey, A. Desbois et al., Extrahepatic manifestations of chronic hepatitis C virus infection, Therapeutic Advances in Infectious Disease, vol.15, issue.3, pp.3-14, 2016.
DOI : 10.1038/gene.2014.41
URL : https://hal.archives-ouvertes.fr/hal-01159323

A. Zignego, C. Ferri, S. Pileri, P. Caini, and F. Bianchi, Extrahepatic manifestations of Hepatitis C Virus infection: A general overview and guidelines for a clinical approach, Digestive and Liver Disease, vol.39, issue.1, pp.2-17, 2007.
DOI : 10.1016/j.dld.2006.06.008

P. Cacoub, L. Gragnani, C. Comarmond, and A. Zignego, Extrahepatic manifestations of chronic hepatitis C virus infection, Digestive and Liver Disease, vol.46, pp.165-173, 2014.
DOI : 10.1016/j.dld.2014.10.005
URL : https://hal.archives-ouvertes.fr/hal-01159323

C. Ferri, M. Sebastiani, D. Giuggioli, M. Colaci, P. Fallahi et al., HCV syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin???s lymphoma, and cancer, World Journal of Hepatology, vol.7, issue.3, pp.327-370, 2015.
DOI : 10.1182/blood-2009-10-245878

Z. Cheng, B. Zhou, X. Shi, Y. Zhang, L. Zhang et al., Extrahepatic manifestations of chronic hepatitis C virus infection: 297 cases from a tertiary medical center in Beijing, China, Chin Med J (Engl), vol.127, pp.1206-1216, 2014.

Z. Younossi, H. Park, S. Saab, A. Ahmed, D. Dieterich et al., Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in??patients with chronic hepatitis C virus genotype 1 infection, Alimentary Pharmacology & Therapeutics, vol.27, issue.Suppl 1, pp.544-63, 2015.
DOI : 10.1111/j.1440-1746.2011.06813.x

L. Henry and Z. Younossi, Patient-reported and economic outcomes related to sofosbuvir and ledipasvir treatment for chronic hepatitis C, Expert Review of Pharmacoeconomics & Outcomes Research, vol.7, issue.10, pp.659-665, 2016.
DOI : 10.3748/WJG.v22.i35.8050

Z. Younossi, M. Singer, H. Mir, L. Henry, and S. Hunt, Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients, Journal of Hepatology, vol.60, issue.3, pp.530-537, 2014.
DOI : 10.1016/j.jhep.2013.11.009

M. Rotily, A. Vainchtock, B. Jouaneton, C. Wartelle-bladou, and A. Abergel, How did chronic hepatitis C impact costs related to hospital health care in France, Clin Res Hepatol Gastroenterol, 2009.
DOI : 10.1016/j.clinre.2012.11.004

Z. Younossi, H. Park, L. Henry, A. Adeyemi, and M. Stepanova, Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of??Prevalence, Quality of Life, and Economic Burden, Gastroenterology, vol.150, issue.7, pp.1599-608, 2016.
DOI : 10.1053/j.gastro.2016.02.039

C. Pioche, C. Pelat, C. Larsen, J. Desenclos, M. Jauffret-roustide et al., Estimation de la prévalence de l'hépatite C en population générale, France métropolitaine, Bull Epidémiol Hebd, pp.13-14224, 2011.

L. Gragnani, M. Visentini, E. Fognani, T. Urraro, D. Santis et al., Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia, Hepatology, vol.27, issue.Suppl. 13, pp.1473-8214, 2016.
DOI : 10.1038/leu.2012.238

M. Sise, A. Bloom, J. Wisocky, M. Lin, J. Gustafson et al., Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents, Hepatology, vol.310, issue.2, pp.408-425, 2016.
DOI : 10.1001/jama.2013.109309

D. Saadoun, V. Thibault, S. Ahmed, S. Alric, L. Mallet et al., Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study, Annals of the Rheumatic Diseases, vol.11, issue.(1 Pt 1), pp.1777-82, 2016.
DOI : 10.1016/j.autrev.2011.07.005

P. Cacoub, V. Ratziu, R. Myers, P. Ghillani, J. Piette et al., Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C, Journal of Hepatology, vol.36, issue.6, pp.812-820, 2002.
DOI : 10.1016/S0168-8278(02)00067-3

Y. Hsu, J. Lin, H. Ho, H. Wang, M. Wu et al., Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients, Hepatology, vol.359, issue.Suppl 1, pp.1293-302, 2014.
DOI : 10.1016/S0140-6736(02)07339-7

Y. Hsu, H. Ho, Y. Huang, H. Wang, M. Wu et al., Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection, Gut, vol.59, issue.3, pp.495-503, 2015.
DOI : 10.1016/j.jclinepi.2006.07.002

A. Thompson, K. Patel, W. Chuang, E. Lawitz, M. Rodriguez-torres et al., Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3, Gut, vol.61, issue.1, pp.128-162, 2012.
DOI : 10.1136/gut.2010.236158

J. Ward and J. Mermin, Simple, Effective, but Out of Reach? Public Health Implications of HCV Drugs, New England Journal of Medicine, vol.373, issue.27, pp.2678-80, 2015.
DOI : 10.1056/NEJMe1513245

A. Abergel, M. Rotily, S. Branchoux, R. Akremi, L. De-léotoing et al., Chronic hepatitis C: Burden of disease and cost associated with hospitalisations in France in 2012 (The HEPC-LONE study), Clinics and Research in Hepatology and Gastroenterology, vol.40, issue.3, pp.340-348, 2016.
DOI : 10.1016/j.clinre.2015.08.006

M. Visentini, S. Colantuono, G. Granata, A. De-santis, M. Fiorilli et al., The case for cost-effectively treating cryoglobulinemic vasculitis with interferon-free anti-hepatitis C virus therapy, Hepatology, vol.60, issue.3, p.975, 2015.
DOI : 10.1002/hep.27151

L. Backus, D. Boothroyd, B. Phillips, P. Belperio, J. Halloran et al., A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C, Clinical Gastroenterology and Hepatology, vol.9, issue.6, pp.509-525, 2011.
DOI : 10.1016/j.cgh.2011.03.004

P. Cacoub, M. Vautier, A. Desbois, A. Lafuma, and D. Saadoun, Effectiveness and cost of hepatitis C virus cryoglobulinemia vasculitis treatment: from interferon-based to direct-acting antivirals, Liver Int
URL : https://hal.archives-ouvertes.fr/hal-01521117

K. Raimundo, A. Farr, G. Kim, and G. Duna, Clinical and Economic Burden of Antineutrophil Cytoplasmic Antibody-associated Vasculitis in the United States, The Journal of Rheumatology, vol.42, issue.12, pp.2383-91, 2015.
DOI : 10.3899/jrheum.150479

M. Lee, H. Yang, S. Lu, C. Jen, S. You et al., Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study, Journal of Infectious Diseases, vol.206, issue.4, pp.469-77, 2012.
DOI : 10.1093/infdis/jis385
URL : https://academic.oup.com/jid/article-pdf/206/4/469/2571090/jis385.pdf